• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAUSCH + LOMB BAUSCH + LOMB INJECTOR SYSTEM CARTRIDGE; FOLDERS AND INJECTORS, INTRAOCULAR LENS (IOL)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAUSCH + LOMB BAUSCH + LOMB INJECTOR SYSTEM CARTRIDGE; FOLDERS AND INJECTORS, INTRAOCULAR LENS (IOL) Back to Search Results
Model Number BLIS-X1
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Vitreous Loss (2142); Capsular Bag Tear (2639); Vitrectomy (2643); No Code Available (3191)
Event Date 10/08/2019
Event Type  Injury  
Manufacturer Narrative
Though requested, no additional information has been received.The product was not returned for evaluation; consequently, no product evaluation was performed.A device history review could not be performed as no lot number has been provided.Based upon the complaint trend review, the volume of complaints is within the acceptable control limits and no complaint trend is observed.The trend analysis, risk analysis and/or directions for use review were considered acceptable, with the product performing within anticipated rates.Proper loading of the intraocular lens (iol) in accordance with the directions for use is essential in facilitating the folding process of the iol.Incorrect loading can result in similar folding issues.In addition, the added viscoelastic (ovd) may also influence the folding of the iol.The iol may rub harder during advancing if too little viscoelastic is applied, or if zones of the loading chamber remain dry.Based on the current information, the root cause of the event could not be conclusively determined; however, user related factors, such as loading issues might have contributed to the event.No corrective action is necessary at this time.
 
Event Description
It was reported that during the insertion of an intraocular lens (iol) there was a lens folding issue with the leading haptic.The incision was enlarged to remove the lens intraoperatively, and sutures were required.Though requested, no additional information has been received.
 
Event Description
The capsular bag was damaged in the right eye, and there was a loss of vitreous.A vitrectomy was performed and the incision was enlarged to remove the intraocular lens (iol).Sutures were used.The iol damage was noticed intraoperatively.The plan of surgery was changed to 3 piece iol, and the second iol was implanted successfully.In the physician¿s opinion, the most likely cause of the iol damage was lens stuck in delivery device.Good patient prognosis.
 
Manufacturer Narrative
The conclusions from the original submission remain unchanged.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BAUSCH + LOMB INJECTOR SYSTEM CARTRIDGE
Type of Device
FOLDERS AND INJECTORS, INTRAOCULAR LENS (IOL)
Manufacturer (Section D)
BAUSCH + LOMB
1400 n. goodman
rochester NY 14609
MDR Report Key9707634
MDR Text Key183908164
Report Number0001313525-2020-00033
Device Sequence Number1
Product Code MSS
Combination Product (y/n)Y
PMA/PMN Number
K131958
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,user facility
Type of Report Initial,Followup
Report Date 01/01/2005,10/23/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberBLIS-X1
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Was the Report Sent to FDA? Yes
Date Report Sent to FDA01/01/2005
Date Report to Manufacturer01/10/2005
Initial Date Manufacturer Received 01/16/2020
Initial Date FDA Received02/13/2020
Supplement Dates Manufacturer Received02/14/2020
Supplement Dates FDA Received03/13/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ENVISTA TORIC INTRAOCULAR LENS
Patient Outcome(s) Required Intervention;
Patient Age91 YR
-
-